Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04289324
Other study ID # 1161/2019
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 25, 2020
Est. completion date June 30, 2024

Study information

Verified date October 2023
Source Medical University of Vienna
Contact Tobias Werther
Phone +4314040032320
Email tobias.werther@meduniwien.ac.at
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess whether stepwise oxygenation-guided lung recruitment at regular intervals reduces the oxygen saturation index (OSI = Mean Airway Pressure × Fraction of inspired Oxygen × 100 / peripheral Oxygen Saturation, OSI = MAPxFiO2x100/SpO2) averaged over high frequency oscillation ventilation (HFOV) time in extremely preterm infants.


Description:

Background: Open lung maneuvers aim to recruit and stabilize the majority of collapsed alveoli, using oxygenation as an indirect variable for lung volume. The stepwise oxygenation-guided lung recruitment procedure during frequency oscillatory ventilation (HFOV) in preterm infants has a low risk of lung hyperinflation and air leak syndrome. Nevertheless, open lung maneuvers at regular intervals during HFOV to maintain or restore oxygenation is not implemented as a routine procedure in the neonatal intensive care. Aim of the study: To assess whether stepwise oxygenation-guided lung recruitment at regular intervals reduces the oxygen saturation index (OSI = Mean Airway Pressure × Fraction of inspired Oxygen × 100 / peripheral Oxygen Saturation, OSI = MAPxFiO2x100/SpO2) averaged over HFOV time in extremely preterm infants. Study design: Single center randomized controlled study. Methods: Thirty-six extremely preterm infants below 28 weeks of gestational age and on high frequency oscillation ventilation receive either stepwise oxygenation-guided lung recruitment maneuver at regular intervals (intervention) and upon decision of the care giving team (intervention group) or lung recruitment maneuver only upon decision of the care giving team (standard, control group). The primary outcome is the oxygen saturation index averaged over HFO ventilation time. The observation time of the HFOV will be limited to at most seven days. Sample size: Fifteen infants need to be enrolled in each group to have 80% power (at a two-sided alpha level of 5%) to detect a difference of 25% in the oxygen saturation index between the intervention group and the control group. Main outcome variables: Oxygen saturation index averaged over HFO ventilation time. Secondary outcome variables: Bronchopulmonary dysplasia (BPD); days of ventilation; oxygen saturation index averaged over ventilation time (HFO and conventional ventilation); the following variables measured before, during and after a single stepwise oxygenation-guided recruitment maneuver: echocardiographic parameters, reactance, relative impedance changes, lung ultrasound measurements, transcutaneous partial carbon dioxide (CO2), blood pressure, heart rate.


Recruitment information / eligibility

Status Recruiting
Enrollment 36
Est. completion date June 30, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers No
Gender All
Age group N/A to 8 Weeks
Eligibility Inclusion Criteria: Preterm infants - born below 28 weeks of gestational age - not older than 29 weeks of postmenstrual age - receive HFOV Exclusion Criteria: - known congenital anomalies of the heart, of the lung, and/or of the central nervous system - known chromosomal abnormalities - participation in other intervention trials

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
regular lung recruitment
stepwise oxygenation-guided lung recruitment at regular (twelve hours) intervals during high frequency oscillation ventilation

Locations

Country Name City State
Austria Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

References & Publications (5)

De Jaegere A, van Veenendaal MB, Michiels A, van Kaam AH. Lung recruitment using oxygenation during open lung high-frequency ventilation in preterm infants. Am J Respir Crit Care Med. 2006 Sep 15;174(6):639-45. doi: 10.1164/rccm.200603-351OC. Epub 2006 Ju — View Citation

de Waal K, Evans N, van der Lee J, van Kaam A. Effect of lung recruitment on pulmonary, systemic, and ductal blood flow in preterm infants. J Pediatr. 2009 May;154(5):651-5. doi: 10.1016/j.jpeds.2009.01.012. — View Citation

Rimensberger PC, Beghetti M, Hanquinet S, Berner M. First intention high-frequency oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with respiratory distress syndrome. Pediatrics. 2000 Jun;105(6): — View Citation

Rimensberger PC, Pache JC, McKerlie C, Frndova H, Cox PN. Lung recruitment and lung volume maintenance: a strategy for improving oxygenation and preventing lung injury during both conventional mechanical ventilation and high-frequency oscillation. Intensi — View Citation

Zannin E, Doni D, Ventura ML, Fedeli T, Rigotti C, Dellaca RL, Tagliabue PE. Relationship between Mean Airways Pressure, Lung Mechanics, and Right Ventricular Output during High-Frequency Oscillatory Ventilation in Infants. J Pediatr. 2017 Jan;180:110-115 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary HFOV oxygen saturation index oxygen saturation index averaged over high frequency oscillation ventilation for not more than seven consecutive days through study completion, an average 10 weeks
Secondary bronchopulmonary dysplasia respiratory support at 36 weeks postmenstrual age through study completion, an average 10 weeks
Secondary days of ventilation days on conventional and high frequency oscillation ventilation through study completion, an average 10 weeks
Secondary overall oxygen saturation index oxygen saturation index averaged over ventilation time through study completion, an average 10 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05134116 - SafeBoosC III Two-year Follow-up
Active, not recruiting NCT03714633 - Stockholm Preterm Interaction-Based Intervention N/A
Not yet recruiting NCT05490173 - The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants N/A
Active, not recruiting NCT04459117 - Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen Phase 2/Phase 3
Completed NCT03649282 - HFNC and NCPAP in Extremely Preterm Infants N/A
Completed NCT01773902 - Protein for Premies N/A
Completed NCT04121897 - Therapist Education and Massage for Parent Infant-Outcomes N/A
Recruiting NCT04413097 - Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants N/A
Recruiting NCT05265195 - PeriviAble DeLiveries: ALIgning PArental aNd PhysiCian PrioritiEs (ALLIANCE)
Completed NCT05686252 - RCT: The Effect of Held Position During Kangaroo Care on Physiological Parameters of Premature Infants N/A
Recruiting NCT06027645 - Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder N/A
Completed NCT04074525 - Evaluating Decisional Regret Among Mothers
Completed NCT05152875 - Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia
Completed NCT02782637 - Prenatal Counseling in Extreme Prematurity: Parents' View N/A
Recruiting NCT04715373 - LISA in the Delivery Room for Extremely Preterm Infants N/A
Not yet recruiting NCT05334550 - Effectiveness of Home Based Early Intervention of Extremely Premature Infant by Parent N/A
Not yet recruiting NCT06220461 - Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants N/A
Recruiting NCT05248477 - Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX) N/A
Completed NCT04652063 - Osteopathic Manipulative Medicine to Reduce Developmental Delays N/A
Completed NCT04256889 - Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA N/A